Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Nuria Monteagudo-Martínez, Julián Solís-García del Pozo, Eduardo Nava, Ichiro Ikuta, Maria Galindo & Joaquin Jordán. (2022) Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis. Expert Review of Anti-infective Therapy 20:11, pages 1477-1489.
Read now
Read now
Chi-Kuei Hsu, Ching-Yi Chen, Wang-Chun Chen, Chien-Ming Chao & Chih-Cheng Lai. (2022) Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy 20:3, pages 435-444.
Read now
Read now
H. Thom, J. C. Thompson, D. A. Scott, N. Halfpenny, K. Sulham & G. R. Corey. (2015) Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis. Current Medical Research and Opinion 31:8, pages 1539-1551.
Read now
Read now
Jennifer M Stephens, Xin Gao, Dipen A Patel, Bram G Verheggen, Ahmed Shelbaya & Seema Haider. (2013) Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin. ClinicoEconomics and Outcomes Research 5, pages 447-457.
Read now
Read now
Beth White & R Andrew Seaton. (2011) Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin. Infection and Drug Resistance 4, pages 115-127.
Read now
Read now
Kimbach Tran Carpiuc, Gianantonio Rosti, Fausto Castagnetti, Maarten Treur & Jennifer Stephens. (2010) Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics. OncoTargets and Therapy 3, pages 205-210.
Read now
Read now
Daniel Curcio. (2010) Resistant pathogen-associated skin and skin-structure infections: antibiotic options. Expert Review of Anti-infective Therapy 8:9, pages 1019-1036.
Read now
Read now
Articles from other publishers (26)
Yunxiang Yan, Yong Liu, Juanjuan Li, Ye Li, Haoheng Wu, Hong Li, Xiang Ma, Yanqiong Tang, Yuan Tong, Kexian Yi, Quanfeng Liang & Zhu Liu. (2023) A Molecular Switch‐Integrated Nanoplatform Enables Photo‐Unlocked Antibacterial Drug Delivery for Synergistic Abscess Therapy. Advanced Healthcare Materials 12:27.
Crossref
Crossref
Ashok Khanal, Sulochan G.C.Amrit Gaire, Aashis Khanal, Rolando Estrada, Rakesh Ghimire & Suresh Panthee. (2021) Methicillin-resistant Staphylococcus aureus in Nepal: A systematic review and meta-analysis. International Journal of Infectious Diseases 103, pages 48-55.
Crossref
Crossref
Roman A. Khmel’nitskij & Аndrej V. Vislobokov. (2020) Clinical feasibility study of an immunotropic drug for treatment of complicated pyodermas. Research Results in Pharmacology 6:3, pages 51-57.
Crossref
Crossref
Vasilios Petrakis, Periklis Panagopoulos & Nikolaos Papanas. (2020) Dalbavancin for the Treatment of Complicated Gram-Positive Skin and Soft Tissue Infections. The International Journal of Lower Extremity Wounds 19:3, pages 236-241.
Crossref
Crossref
Matteo Bassetti & Elda Righi. 2020. Approaching Complex Diseases. Approaching Complex Diseases
457
480
.
Elda Righi, Alessia Carnelutti & Matteo Bassetti. (2019) Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections. Current Opinion in Infectious Diseases 32:2, pages 123-129.
Crossref
Crossref
Matteo Bassetti, Maddalena Peghin, Alessia Carnelutti & Elda Righi. (2018) The role of dalbavancin in skin and soft tissue infections. Current Opinion in Infectious Diseases 31:2, pages 141-147.
Crossref
Crossref
Julian F. Guest, Jaime Esteban, Anton G. Manganelli, Andrea Novelli, Giuliano Rizzardini & Miquel Serra. (2017) Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis. PLOS ONE 12:11, pages e0187792.
Crossref
Crossref
Christos Tsoulas & Dilip Nathwani. (2015) Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?. International Journal of Antimicrobial Agents 46:1, pages 1-7.
Crossref
Crossref
Matteo Bassetti, Jan J. De Waele, Philippe Eggimann, Josè Garnacho-Montero, Gunnar Kahlmeter, Francesco Menichetti, David P. Nicolau, Jose Arturo Paiva, Mario Tumbarello, Tobias Welte, Mark Wilcox, Jean Ralph Zahar & Garyphallia Poulakou. (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Medicine 41:5, pages 776-795.
Crossref
Crossref
Shigeto Oda, Mayuki Aibiki, Toshiaki Ikeda, Hitoshi Imaizumi, Shigeatsu Endo, Ryoichi Ochiai, Joji Kotani, Nobuaki Shime, Osamu Nishida, Takayuki Noguchi, Naoyuki Matsuda & Hiroyuki Hirasawa. (2014) The Japanese guidelines for the management of sepsis. Journal of Intensive Care 2:1.
Crossref
Crossref
Kostas Athanasakis, Ioannis Petrakis, Mark Ollandezos, Christos Tsoulas, Dipen A. Patel, Eleftheria Karampli & John Kyriopoulos. (2014) Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals. Infectious Diseases and Therapy 3:2, pages 257-268.
Crossref
Crossref
Esther Bettiol, Wouter C Rottier, Maria Dolores del Toro, Stephan Harbarth, Marc J Bonten & Jesús Rodríguez-Baño. (2014) Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies. Future Microbiology 9:6, pages 757-771.
Crossref
Crossref
Laura A. Puzniak, Alvaro Quintana, Michele Wible, Tim Babinchak & Paul C. McGovern. (2014) Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trials. Diagnostic Microbiology and Infectious Disease 79:2, pages 261-265.
Crossref
Crossref
Warren S. JosephThomas QuastAlberto CogoMonica G. CromptonMin Jung YoonKenneth C. LampDarren CulshawRicardo L. Chaves. (2014) Daptomycin for Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections. Journal of the American Podiatric Medical Association 104:2, pages 159-168.
Crossref
Crossref
Ewa Szczypinska, Alexander Velazquez, Diana Salazar, C Andrew DeRyke, Beata Raczynski & Mark R Wallace. (2013) The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections. SpringerPlus 2:1.
Crossref
Crossref
Xingyue Huang, Eric Beresford, Thomas LodiseH. David Friedland. (2013) Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective. American Journal of Health-System Pharmacy 70:12, pages 1057-1064.
Crossref
Crossref
S. J. Vandecasteele, A. S. De Vriese & E. Tacconelli. (2012) The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. Journal of Antimicrobial Chemotherapy 68:4, pages 743-748.
Crossref
Crossref
Michèle Bally, Nandini Dendukuri, Alison Sinclair, Stéphane P. Ahern, Michel Poisson & James Brophy. (2012) A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection. International Journal of Antimicrobial Agents 40:6, pages 479-495.
Crossref
Crossref
L. Tognetti, C. Martinelli, S. Berti, J. Hercogova, T. Lotti, F. Leoncini & S. Moretti. (2012) Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment. Journal of the European Academy of Dermatology and Venereology 26:8, pages 931-941.
Crossref
Crossref
Ian M. Gould, Michael Z. David, Silvano Esposito, Javier Garau, Gerard Lina, Teresita Mazzei & Georg Peters. (2012) New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. International Journal of Antimicrobial Agents 39:2, pages 96-104.
Crossref
Crossref
José Barberán & M. Carmen Fariñas. (2012) Tratamiento con daptomicina en las infecciones complicadas de piel y partes blandas. Enfermedades Infecciosas y Microbiología Clínica 30, pages 33-37.
Crossref
Crossref
Adam J. Friedman, Karin Blecher, David Schairer, Chaim Tuckman-Vernon, Parimala Nacharaju, David Sanchez, Philip Gialanella, Luis R. Martinez, Joel M. Friedman & Joshua D. Nosanchuk. (2011) Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide 25:4, pages 381-386.
Crossref
Crossref
F. K. Gould. (2011) Linezolid: safety and efficacy in special populations. Journal of Antimicrobial Chemotherapy 66:Supplement 4, pages iv3-iv6.
Crossref
Crossref
Theodoros Kelesidis. (2011) Safety and Efficacy of Daptomycin in the Treatment of Gram-Positive Pathogens. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6122.
Crossref
Crossref
P Kujath & C Kujath. (2010) Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?. European Journal of Medical Research 15:12.
Crossref
Crossref